Home LiteratureArticle Details
PMID: 12792760 Published · ppublish English Journal Article

Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.

Oncology reports ·Vol. 10 ·No. 4 ·2003-00-00 ·Pages 1001-6

Fujiuchi Y, Nagakawa O, Murakami K, Fuse H, Saiki I

Abstract

Hepatocyte growth factor (HGF) was suggested to play an important role in the regulation of mitogenesis, motogenesis, angiogenesis, migration and invasion for various types of cells, and acts through a specific membrane receptor encoded by c-met proto-oncogene. However, the mechanism of the effect of HGF on tumor invasion of prostate cancer cells remains unclear. We investigated the effect of HGF on the invasion of PC-3 and DU-145 prostate cancer cells through a reconstituted basement membrane (Matrigel), the haptotactic migration to fibronectin substrate, the expression of protein and mRNA for matrix metalloproteinases (MMP)-1 and -9, membrane-type 1-MMP (MT1-MMP), urokinase-type plasminogen activator (u-PA) and its receptor (uPAR). HGF increased both Matrigel invasion and haptotactic migration of prostate cancer cells. Furthermore, HGF also increased the production of MMP-1 and -9, MT1-MMP, u-PA and uPAR of these cells. These results suggested that HGF increased the invasive potential of prostate cancer cells probably through enhancement of cell motility and the production of MMPs and u-PA.

MeSH Terms
Antineoplastic Agents/metabolism Cell Adhesion/drug effects Cell Movement/drug effects Collagen Drug Combinations Fibrin/metabolism Hepatocyte Growth Factor/pharmacology Humans Laminin Male Matrix Metalloproteinase 1/genetics,metabolism Matrix Metalloproteinase 9/genetics,metabolism Neoplasm Invasiveness Prostatic Neoplasms/enzymology,pathology Proteoglycans Proto-Oncogene Mas RNA, Messenger/metabolism RNA, Neoplasm/genetics Receptors, Cell Surface/genetics,metabolism Receptors, Urokinase Plasminogen Activator Recombinant Proteins/pharmacology Reverse Transcriptase Polymerase Chain Reaction Tissue Inhibitor of Metalloproteinase-1/genetics,metabolism Tumor Cells, Cultured Urokinase-Type Plasminogen Activator/genetics,metabolism
Chemicals
Antineoplastic Agents Drug Combinations Laminin MAS1 protein, human PLAUR protein, human Proteoglycans Proto-Oncogene Mas RNA, Messenger RNA, Neoplasm Receptors, Cell Surface Receptors, Urokinase Plasminogen Activator Recombinant Proteins Tissue Inhibitor of Metalloproteinase-1 matrigel Hepatocyte Growth Factor Fibrin Collagen Urokinase-Type Plasminogen Activator Matrix Metalloproteinase 9 Matrix Metalloproteinase 1
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fujiuchi Yasuyoshi
Department of Urology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. fujiuchi@ms.toyama-mpu.ac.jp
Nagakawa Osamu
Murakami Koji
Fuse Hideki
Saiki Ikuo
Article Info
Journal
Oncology reports
Abbr.
Oncol Rep
ISSN
1021-335X
Published
2003-00-00
Pages
1001-6
Language
English
Region
Greece
NLM ID
9422756
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com